---
title: "Design a system for safe LLM deployment in healthcare"
description: "Healthcare adds three constraints on top of normal LLM deployment: regulatory compliance, low tolerance for harm, and a workflow that already has clinicians as the final decision-maker."
date: "2026-05-07"
draft: false
tags: ["interviews"]
category: "interviews"
---


> *Asked in: healthtech LLM interviews; safety / responsible-AI roles.*

The L4 answer is generic LLM deployment with extra logging. The L6 answer treats the clinician as a first-class part of the system and designs around regulatory, audit, and harm-floor requirements.

## What an L4 answer sounds like

> "Add disclaimers, log everything, and have a human review the outputs."

This is a starting point, not an answer. It misses the regulatory framing, the workflow integration, and the operational discipline. You've heard the buzzwords.

## What an L5 answer sounds like

> "Healthcare has three additional constraints:
>
> 1. **Regulatory**: HIPAA for data, FDA for medical-device-classified software, GDPR/local equivalents.
> 2. **Harm floor**: a hallucinated diagnosis or treatment recommendation can directly harm patients.
> 3. **Workflow**: clinicians are the decision-makers. The system supports them; it doesn't replace them.
>
> Architecture choices that follow:
>
> **Scope tightly.** Use LLMs for clearly bounded tasks: documentation drafting, summarization of patient records, retrieval of guidelines, structured data extraction. Avoid open-ended diagnosis or treatment recommendation in v1.
>
> **Ground in trusted sources.** RAG over verified medical literature, clinical guidelines, and the patient's own records. Refuse to answer from model knowledge alone for clinical questions.
>
> **Citations are mandatory.** Every clinical claim must trace to a source the clinician can verify in seconds.
>
> **Confidence-aware UI.** Surface uncertainty explicitly. Distinguish 'high-confidence summary' from 'best-effort interpretation'. Make refusal a visible, normal output.
>
> **Human-in-the-loop by default.** No clinical action triggered by LLM output without clinician confirmation. The LLM drafts; the clinician decides.
>
> **Audit trail end-to-end.** Every input, retrieval, generation, citation, clinician acceptance/edit logged for review."

This is L5. You've named the constraints and let them drive the architecture.

## What an L6 answer adds

> "...practical operational considerations:
>
> **Eval is harder than usual.** Generic LLM benchmarks are useless; medical benchmarks (USMLE-style, MedQA) test knowledge but not safety. Build evals from real clinical workflows, scored by clinicians, with explicit failure-mode tracking. Pre-launch eval should include adversarial cases (prompts likely to elicit dangerous outputs) and edge cases the team's clinical advisors flag.
>
> **Refusal-rate is a metric, not a failure mode.** A model that refuses appropriately on out-of-scope clinical questions is *better* than one that confidently makes things up. Track refusal rate per category; tune to balance helpfulness against the harm floor.
>
> **Bias and fairness are first-order.** LLMs encode biases from training data; in clinical contexts these can produce demographic disparities in care. Slice eval by demographic dimensions; gate launches on no-regression.
>
> **Regulatory categorization drives the build.** If the system is FDA-classified Software as a Medical Device (SaMD), the validation, documentation, and change-management requirements are enormous. Many teams scope explicitly to non-SaMD use cases (admin, documentation) to avoid this.
>
> **Incident response is part of the architecture.** When (not if) something goes wrong, you need: traceable logs, rapid revert, communication path to affected clinicians and patients, regulatory disclosure procedures. Build the response plan before launch.
>
> **Limit model autonomy through the prompt and output structure.** Output is structured (e.g., 'suggested differential' rather than free prose), with defined fields, defined refusal language. Constrains both the model's failure modes and the clinician's expectations."

## Tells that get you a strong-hire vote

- You **scope tightly** (admin tasks, documentation, structured extraction; avoid open-ended diagnosis in v1).
- You name **HIPAA, FDA SaMD** explicitly and let them drive scope.
- You make **clinician-in-the-loop** the default architecture.
- You treat **refusal as a feature**, not a failure.
- You bring up **fairness slices** and **incident response**.

## Tells that get you down-leveled

- Suggesting an LLM diagnoses or treats patients in v1.
- Adding "disclaimers" as the safety strategy.
- No regulatory awareness.
- No mention of bias or demographic slicing.

## Common follow-up

"How would you handle a clinician who consistently overrides the LLM's correct outputs?"

The L6 answer:

> "Two angles. From the system perspective: log the override pattern, surface to the clinician their override-vs-system-correctness rate, and analyze the disagreement pattern (is the clinician right and the system wrong, or vice versa, or are they disagreeing on judgment calls?). From the human perspective: clinicians are the responsible parties; their judgment overrides the LLM by design. The system's job is to make their decision easier and traceable, not to coerce. If the override rate is consistently high, that's a signal the system isn't useful to that clinician, not that the clinician needs to change."

---

*Related: [How do you handle hallucinations in production?](/interviews/handle-hallucinations-in-production/), [LLM Evals essay](/essays/llm-evals-the-hardest-part/), [RAG for legal documents](/interviews/rag-for-legal-docs/).*
